Highlights of April 2023 1. Cash rich Serum Institute of India to double investment in Biocon's unit to INR 2,455...
Read MoreHighlights of March 2023:Aurobindo, Cipla, Viatris in licensing pact with MPP(Medicine Patent Pool) to make ViiV's HIV preventive therapy.Lotus Surgic...
Read MoreHighlights of February 2023:India's Biocon raises US$129 Million from Kotak to fund biosimilars deal.Marengo Asia Healthcare acquires 1...
Read MoreHighlights of January 2023Sun Pharma acquires U.S.-based Concert Pharma for $576 million, to gain access to its experimental drug for treating patchy ...
Read MoreHighlights of December 2022Private equity giant Advent International will acquire a 50.1% stake in Suven Pharmaceuticals from Jasti family for nearly ...
Read MoreHighlights of November 2022Gland Pharma buys Cenexi Group for €120 Million.Mankind Pharma acquires majority stake in Upakarma Ayurveda.Lupin's Brazi...
Read MoreHighlights of October 2022Lupin Signs Agreement to Acquire Two Inhalation Brands from Sunovion.Hetero acquires Johnson & Johnson's manufacturing p...
Read MoreHighlights of September 2022Lupin, DKSH sign agreement to commercialize five biosimilar candidates in Philippines.Dr. Reddy’s Labs partners with IQV...
Read MoreHighlights of August 2022Aurobindo Pharma completes acquisition of 51% stake in GLS Pharma.Lupin and I’rom enter into exclusive licensing agreement ...
Read MoreHighlights of July 2022Dr. Reddy's Labs acquires injectable product portfolio from Eton Pharma.Aurigene inks drug discovery partnership with EQRx.Zena...
Read More